A Phase 3b Study Evaluating the 24-Hour Intraocular Pressure Lowering Effect of Bimatoprost SR in Patients With Open-Angle Glaucoma or Ocular Hypertension
Study Identifier
1698-304-007
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Results Available
Protocol
Available Language(s): English
Statistical Analysis Plan
Available Language(s): English
Plain Language Summary
Available Language(s): English
Scientific Result Summary
Available Language(s): English
Study Details
Medical Condition
Study Drug
Phase
Phase 3
Sex
Female & Male
Age
18+ years
Protocol Summary
This study will evaluate the 24-hour intraocular pressure lowering effect and safety after a single administration of Bimatoprost SR in patients with Open-Angle Glaucoma or Ocular Hypertension
Study Locations
Location
Status
Location
Trinity Research Group /ID# 232749
Dothan, Alabama, United States, 36301
Status
Not applicable
Location
The Eye Research Foundation /ID# 232694
Newport Beach, California, United States, 92663-3637
Status
Not applicable
Location
Coastal Research Associates /ID# 232798
Roswell, Georgia, United States, 30076
Status
Not applicable
Location
James D Branch MD /ID# 232718
Winston-Salem, North Carolina, United States, 27101
Status
Not applicable
Location
Scott and Christie and Associates /ID# 232747
Cranberry Township, Pennsylvania, United States, 16066
Status
Not applicable
Location
Keystone Research LTD /ID# 232665
Austin, Texas, United States, 78731-4203
Status
Not applicable